Vol.

No.

March 29, 2019Mar 29, 2019

DOWNLOAD THE PDF

NCCN validates path toward de-escalated doses and reduced costs of cancer drugs

Cover Story

Free Guest Editorial

NCCN validates path toward de-escalated doses and reduced costs of cancer drugs

By Allen S. Lichter, Mark J. Ratain, Leonard B. Saltz, Michael Stebbins and David Hyman

The ever-rising cost of oncology drugs is doing damage to cancer care on many levels.

Cancer is a model for drug development, FDA-bound Sharpless says to NCI advisors

By Paul Goldberg

Guest Editorial

Congress must commit to sustained increases for NCI

By Brian Higgins and Peter King

Free Letter To The Editor

Gundry: saguaro cacti do not grow in Texas

Antoni Ribas named AACR president-elect for 2019-2020 term

Daniel Von Hoff, Louis Weiner, Nancy Goodman to receive AACR Distinguished Public Service Awards

AACR announces 2019 Class of Fellows of the AACR Academy

Clinical Conversation with The Cancer Letter

Lee Schwartzberg tells us how three practices banded together to adapt to today's cancer care and data revolution

By Matthew Bin Han Ong

In Brief

Sara Hook named associate director for NCI at Frederick

GW Cancer Center receives $4M award for technical assistance to CDC National Comprehensive Cancer Control Program grantees

Groups urge Congress to close Medicare loophole for colorectal cancer screenings

Ali McBride to serve as ACCC president 2019-2020

Funding Opportunities

DoD Kidney Cancer Research Program- Funding Opportunities for FY19

DoD lung cancer research program funding opportunities for FY19

Clinical Roundup

Fulvestrant plus Anastrozole extends lives of women with advanced HR+ breast cancer

Study finds heating up tumors could make CAR-T therapy more effective

Study shows patients with or without cancer use different forms of marijuana

Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer

Drugs & Targets

FDA advances policy changes to modernize mammography services

FDA issues alert on the investigational use of Venclexta in multiple myeloma

Janssen submits application for Darzalex combination in multiple myeloma

Breath Diagnostics, Mayo collaborate to develop diagnostic using patients' exhaled breath to detect lung cancer

Oncoceutics and NCI partner to develop ONC206

Elicio Therapeutics launches vaccine & immunotherapy platform

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 43 - November 21, 2025

NCCN validates path toward de-escalated doses and reduced costs of cancer drugs

Cancer is a model for drug development, FDA-bound Sharpless says to NCI advisors

Congress must commit to sustained increases for NCI

Gundry: saguaro cacti do not grow in Texas

Antoni Ribas named AACR president-elect for 2019-2020 term

Daniel Von Hoff, Louis Weiner, Nancy Goodman to receive AACR Distinguished Public Service Awards

AACR announces 2019 Class of Fellows of the AACR Academy

Lee Schwartzberg tells us how three practices banded together to adapt to today's cancer care and data revolution

In Brief

Sara Hook named associate director for NCI at Frederick

GW Cancer Center receives $4M award for technical assistance to CDC National Comprehensive Cancer Control Program grantees

Groups urge Congress to close Medicare loophole for colorectal cancer screenings

Ali McBride to serve as ACCC president 2019-2020

Funding Opportunities

DoD Kidney Cancer Research Program- Funding Opportunities for FY19

DoD lung cancer research program funding opportunities for FY19

Clinical Roundup

Fulvestrant plus Anastrozole extends lives of women with advanced HR+ breast cancer

Study finds heating up tumors could make CAR-T therapy more effective

Study shows patients with or without cancer use different forms of marijuana

Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer

Drugs & Targets

FDA advances policy changes to modernize mammography services

FDA issues alert on the investigational use of Venclexta in multiple myeloma

Janssen submits application for Darzalex combination in multiple myeloma

Breath Diagnostics, Mayo collaborate to develop diagnostic using patients' exhaled breath to detect lung cancer

Oncoceutics and NCI partner to develop ONC206

Elicio Therapeutics launches vaccine & immunotherapy platform

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login